Investigation of maintenance of efficacy for 24 hours after teneligliptin administration, and the mechanism of action.
Phase of Trial: Phase IV
Latest Information Update: 18 May 2016
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 12 Aug 2013 New trial record